Journal of aging and health
July 24, 2024
Fatemeh Talebisiavashani, Mohsen Mohammadi-Sartang
6 citations
To assess whether mindfulness-based interventions (MBIs) affect mental health and cognitive abilities in older adults. A systematic search was performed in PubMed, SCOPUS, Web of Science, and Google Scholar up to June 2023. Weight mean difference and 95% confidence intervals were provided as summary statistics. In total, 26 articles were eligible. Overall, MBIs showed a statistically...
Journal of Ayurveda and Integrated Medical Sciences
July 23, 2024
Divya Sharma, B R Sharma
Background: Meditation that has been a practice for millennia in the present era has gained immense popularity as a stress-coping tool and overall health management and improvement method. Research significantly supports meditation efficacy, revealing beneficial brain and biological changes, leading to improved mental and physical well-being.[1] Methods: Based on an extensive review of...
Scientific Reports
July 23, 2024
Guy W. Fincham, Elissa S Epel, Alessandro Colasanti et al.
High ventilation breathwork with retention (HVBR) has been growing in popularity over the past decade and might be beneficial for mental and physical health. However, little research has explored the potential therapeutic effects of brief, remotely delivered HVBR and the tolerability profile of this technique. Accordingly, we investigated the effects of a fully-automated HVBR protocol, along...
Science Insights
July 22, 2024
Kaley Cho
Mindful meditation, a practice that entails directing one’s attention to the current moment without forming judgments, has been acknowledged as a potentially efficacious therapeutic intervention in clinical settings. Evidence indicates that mindfulness-based interventions can effectively assist individuals in coping with a range of mental health conditions, including anxiety, depression, and...
Akademik Platform İslami Araştırmalar Dergisi
July 22, 2024
This research explores the valuable intersections and synergies between Sufism and transpersonal psychology, focusing on how these two disciplines can provide deep insights and solutions to social and individual challenges in the modern era. Facing an identity crisis, existential anxiety, and an increasingly urgent search for the meaning of life, this study shows that Sufism and transpersonal...
Scientific Reports
July 17, 2024
Sara de la Salle, Hannes Kettner, Julien Thibault Lévesque et al.
21 citations
Recent clinical trials have found that the serotonergic psychedelic psilocybin effectively alleviates anxiodepressive symptoms in patients with life-threatening illnesses when given in a supportive environment. These outcomes prompted Canada to establish legal pathways for therapeutic access to psilocybin, coupled with psychological support. Despite over one-hundred Canadians receiving...
Psychiatria Danubina
July 17, 2024
Astrid Kaiserman, Charles Kornreich, Laetitia Vanderijst
1 citation
Psychedelics are currently undergoing a scientific renaissance, with modern studies investigating therapeutic efficacy of psychedelic-assisted therapy in a range of psychiatric conditions. In particular, psilocybin-assisted therapy (PAT) has been suggested to have positive effects on patients suffering from depression and psychiatric distress associated with life-threatening disease - contexts...
World Journal of Clinical Oncology
July 16, 2024
Husam Bader, Husam Farraj, Joud Maghnam et al.
11 citations
BACKGROUND Psilocybin, a naturally occurring psychedelic compound found in certain species of mushrooms, is known for its effects on anxiety and depression. It has recently gained increasing interest for its potential therapeutic effects, particularly in patients with advanced cancer. This systematic review and meta-analysis aim to evaluate the effects of psilocybin on adult patients with...
European Archives of Psychiatry and Clinical Neuroscience
July 13, 2024
Jenessa N Johnston, Carlos A. Zarate, Mark D Kvarta
18 citations
The discovery of racemic (R, S)-ketamine as a rapid-acting antidepressant and the subsequent FDA approval of its (S)-enantiomer, esketamine, for treatment-resistant depression (TRD) are significant advances in the development of novel neuropsychiatric therapeutics. Esketamine is now recognized as a powerful tool for addressing persistent symptoms of TRD compared to traditional oral...
ACS Pharmacology & Translational Science
July 12, 2024
Albert Dahan, Simone C Jansen, Rutger van der Schrier et al.
8 citations
The anesthetic, analgesic and antidepressant drug ketamine produces dissociation with symptoms of psychosis and anxiety, an effect attributed to neuronal nitric oxide depletion following N-methyl-d-aspartate blockade. There is evidence that dissociation induced by racemic ketamine, containing both ketamine enantiomers (S- and R-ketamine) but not esketamine (the S-isomer) is inhibited by nitric...